Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · IEX Real-Time Price · USD
8.46
-0.46 (-5.11%)
Jan 27, 2022 3:47 PM EST - Market open

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019
Net Income
-26.52-5.1
Depreciation & Amortization
0.330.1
Share-Based Compensation
0.330.29
Other Operating Activities
0.3-6.1
Operating Cash Flow
-25.57-10.8
Capital Expenditures
-2.32-0.63
Investing Cash Flow
-2.32-0.63
Share Issuance / Repurchase
0.250.04
Other Financing Activities
49.840
Financing Cash Flow
50.090.04
Net Cash Flow
22.2-11.39
Free Cash Flow
-27.89-11.43
Free Cash Flow Per Share
-3.49-1.69
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).